Lemaitre Vascular (LMAT) Non-Current Assets (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Non-Current Assets came in at $151.7 million in Q1 2026, up 2.58% year-on-year from $147.9 million in Q1 2025, and up 2.88% on a QoQ basis from $147.5 million in Q4 2025.
Lemaitre Vascular (LMAT) Non-Current Assets (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Non-Current Assets data on file, last reported at $151.7 million in Q1 2026.
- On a quarterly basis, Non-Current Assets rose 2.58% year-over-year to $151.7 million in Q1 2026; TTM through Mar 2026 was $592.7 million, a 0.84% decrease from a year earlier, with the FY2025 full-year figure at $147.5 million, down 1.45% from the prior year.
- Non-Current Assets for Q1 2026 stood at $151.7 million, up from $147.5 million in the prior quarter.
- Over the last five years, Non-Current Assets for LMAT reached as high as $152.2 million in Q4 2023 and fell as low as $146.0 million in Q3 2025.
- Historically, Non-Current Assets has averaged $149.8 million across 5 years, with a median of $150.1 million in 2023.
- Across the five-year window, Non-Current Assets slipped 4.21% in 2022 and grew 2.58% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at $148.7 million in 2022, then grew by 2.31% to $152.2 million in 2023, then retreated by 1.68% to $149.6 million in 2024, then slipped by 1.45% to $147.5 million in 2025, then grew by 2.88% to $151.7 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $151.7 million in Q1 2026, $147.5 million in Q4 2025, and $146.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn | 151.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.71 Mn |
| Dec 31, 2025 | 147.46 Mn |
| Sep 30, 2025 | 146.04 Mn |
| Jun 30, 2025 | 147.47 Mn |
| Mar 31, 2025 | 147.89 Mn |
| Dec 31, 2024 | 149.63 Mn |
| Sep 30, 2024 | 149.91 Mn |
| Jun 30, 2024 | 150.27 Mn |
| Mar 31, 2024 | 151.00 Mn |
| Dec 31, 2023 | 152.18 Mn |
| Sep 30, 2023 | 151.83 Mn |
| Jun 30, 2023 | 151.98 Mn |
| Mar 31, 2023 | 150.10 Mn |
| Dec 31, 2022 | 148.74 Mn |
| Sep 30, 2022 | 148.91 Mn |
| Jun 30, 2022 | 150.94 Mn |
| Mar 31, 2022 | 151.04 Mn |
| Dec 31, 2021 | 152.92 Mn |
| Sep 30, 2021 | 155.46 Mn |
| Jun 30, 2021 | 156.49 Mn |